Two analysts currently publish twelve-month price targets on Amplify Energy Corp. (AMPY). Alliance Global Partners analyst Poe Fratt maintains a Buy rating with a $6.50 target (reiterated in August 2026), while Subash Chandra, who has covered the name at Benchmark Co. and more recently StoneX, reiterates a Buy with a $9.00 target, trimmed from $11.00 in August 2026. The resulting range is $6.50 to $9.00, and the arithmetic mean of these two verified targets is $7.75.
The wide spread is telling. The lower target reflects a conservative view of a smaller, leaner asset base after the company divested its Eagle Ford position in 2025, while the higher target gives more credit to accelerated development of the Beta field and the removal of debt. Neither figure should be read as a guarantee; the gap simply underscores how differently two analysts value the same asset set. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.
As of late October 2026, AMPY traded around $4.27, toward the lower half of a 52-week range of roughly $3.65 to $6.79. Reaching the $7.75 central target would require an advance of approximately 81% from that level — a very large move, and one that would take the stock above its prior 52-week high.
The path would depend on restoring production growth after asset sales, converting Beta field development into sustained cash flow, and convincing investors to pay a higher multiple for what is now a smaller, California-focused producer. The stock's P/E (price-to-earnings ratio) in the single digits suggests the market is applying a discount to the company's cyclical earnings power.
Several developments give the bullish case a foundation. Amplify has eliminated borrowings under its revolving credit facility following its asset divestitures, leaving roughly $36 million in liquidity. Management authorized a $15 million buyback — about 10% of the shares outstanding at the time — signaling confidence in intrinsic value. At the Beta field, a roughly 50% royalty-rate reduction, bringing the effective rate to about 12.5%, and strong initial production from new wells have improved cash margins and net output. These factors underpin analysts' reasoning for targets above the current share price.
The obstacles are equally concrete. After the divestitures, total production has declined, and analysts project third-quarter revenue to fall more than 30% year over year. Consensus fiscal 2026 estimates have been reduced, with revenue expectations trimmed to roughly $156 million and EPS (earnings per share) to about $0.27. A history of missed expectations, a sub-scale market capitalization near $177 million, and sensitivity to oil and natural gas prices all weigh on sentiment. If commodity prices soften or Beta development underdelivers, the valuation gap to $7.75 could persist.
From a technical standpoint, the shares sit below the 200-day simple moving average, a sign of weak near-term trend momentum. The prior 52-week high near $6.79 stands as the first significant overhead level, followed by the psychological and analyst-derived markers at $7.25 and the $7.75 central target. Support is evident near the recent lows around $3.65, with the stock having traded in a broad range through 2026. From what I see, monitoring these levels closely helps frame realistic expectations.
Analyst price targets typically reflect a roughly twelve-month research horizon, though the two firms covering the stock have not publicly aligned on identical assumptions. The most immediate catalyst is the company's next earnings report, expected in early November 2026. Investors should watch production guidance, Beta field well results, buyback execution, commodity price trends, and any revisions to the analyst targets themselves, which would signal a shifting consensus on the company's post-divestiture trajectory.
The $7.75 central target — the mean of two Buy-rated analyst targets spanning $6.50 to $9.00 — represents an ambitious objective for a stock trading near $4.27, implying roughly 81% upside. The bullish case rests on a debt-free balance sheet, a share buyback, and improving Beta field economics, while the bearish case points to declining production, lowered 2026 estimates, and weak technical positioning. The wide analyst range reflects genuine uncertainty rather than consensus. Whether Amplify Energy can close that gap will depend on production execution, commodity prices, and whether the market is willing to re-rate a smaller, California-focused producer. No outcome is assured.
In my research process, I often turn to Tickeron's AI Daily Buy/Sell Signals to get an additional layer of insight on names like AMPY. This tool applies artificial intelligence to scan thousands of stocks and ETFs in real time, delivering Buy, Sell, or Hold signals based on technical patterns and market shifts. It has become a useful complement to traditional analysis when evaluating opportunities or managing risk in volatile sectors.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.
The RSI Oscillator for AMPY moved out of oversold territory on September 30, 2026. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 31 similar instances when the indicator left oversold territory. In 28 of the 31 cases the stock moved higher. This puts the odds of a move higher at 90%.
The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 1 day, which means it's wise to expect a price bounce in the near future.
Following a +4.14% 3-day Advance, the price is estimated to grow further. Considering data from situations where AMPY advanced for three days, in 222 of 279 cases, the price rose further within the following month. The odds of a continued upward trend are 80%.
The Momentum Indicator moved below the 0 level on October 29, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on AMPY as a result. In 86 of 111 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 77%.
The Moving Average Convergence Divergence Histogram (MACD) for AMPY turned negative on October 28, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 49 similar instances when the indicator turned negative. In 40 of the 49 cases the stock turned lower in the days that followed. This puts the odds of success at 82%.
AMPY moved below its 50-day moving average on October 14, 2026 date and that indicates a change from an upward trend to a downward trend.
The 10-day moving average for AMPY crossed bearishly below the 50-day moving average on September 28, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 13 of 18 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 72%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where AMPY declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 75%.
AMPY broke above its upper Bollinger Band on October 08, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Tickeron Valuation Rating of 14 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.403) is normal, around the industry mean (3.876). P/E Ratio (8.373) is within average values for comparable stocks, (4.118). Projected Growth (PEG Ratio) (0.130) is also within normal values, averaging (1.958). Dividend Yield (0.094) settles around the average of (0.045) among similar stocks. P/S Ratio (0.874) is also within normal values, averaging (5.980).
The Tickeron Price Growth Rating for this company is 58 (best 1 - 100 worst), indicating fairly steady price growth. AMPY’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is 79 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is 83 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 89 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. AMPY’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 71, placing this stock worse than average.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
an independent oil and natural gas company, which engages in acquisition, development, exploration and production of oil and natural gas properties
Industry OilGasProduction